A new white paper from the Association of Clinical Research Professionals (ACRP) assesses the significant implications of how decentralized clinical trials (DCTs) leverage digital technologies to interact remotely with trial participants. The paper, which can be accessed in the following link, Decentralized Clinical Trials: Perspectives for Clinical Research Professionals, is authored by members of ACRP’s Fellows Advisory Panel who note that vastly increased DCT usage in the past two years has enabled clinical research to advance during the COVID-19 pandemic as part of a trend that is forecast to continue.
Read more about the release of the white paper here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.